News

Chewy's Third Quarter Financial Report Reflects Growth

Chewy's Third Quarter Financial Report Reflects Growth

Chewy Reports Third Quarter Financial Results

Chewy, Inc. (NYSE: CHWY) has recently announced its financial results for the third quarter, highlighting a series of impressive achievements that underline the company’s commitment to pet parents and partners worldwide. With net sales reaching $2.88 billion, this marks a 4.8% year-over-year increase, reflecting Chewy's robust business model and strategic execution.

Highlights of Fiscal Q3 2024

The results from the third quarter illustrate key financial performances:

  • Net sales hit $2.88 billion, an increase of 4.8% compared to the previous year.
  • Gross margin improved to 29.3%, showing an 80 basis point rise year over year.
  • Net income amounted to $3.9 million, factoring in share-based compensation and related taxes, totaling $80.4 million.
  • Net margin increased to 0.1%, a significant growth of 140 basis points from last year.
  • Basic and diluted earnings per share were $0.01, representing a $0.09 increase year over year.
  • Adjusted EBITDA climbed to $138.2 million, marking a year-over-year increase of $55.7 million.
  • Adjusted EBITDA margin reached 4.8%, boosted by a 180 basis point increase from the previous year.
  • Adjusted net income surged to $84.9 million, reflecting a $21.5 million increase compared to the last year.
  • Adjusted earnings per share improved to $0.20, an increase of $0.05 from the prior year.

Sumit Singh, Chewy's CEO, stated, "Our third quarter results continued to build on the positive momentum we observed in Q2. We achieved top-line growth exceeding our anticipated guidance range and saw a sequential increase in active customers. Our team’s unwavering focus on quality and operational discipline is truly evident in these outcomes. We are excited about the future and the ongoing engagement with our customers."

Upcoming Events and Webcast

To discuss these financial results in detail, Chewy’s management has scheduled a conference call and webcast at 8:00 am ET. This will be an opportunity for stakeholders to gain further insights into the company's performance and strategy.

About Chewy, Inc.

Chewy's mission is to be the most trusted and convenient source for pet parents and partners everywhere. The company is recognized as a premier online provider of pet products, supplies, and prescriptions. Chewy collaborates with around 3,500 trusted brands in the pet industry, offering an impressive selection of approximately 115,000 products and services. The company's focus lies on enhancing customer experience through innovative platforms that allow easy management of pets’ health and wellness. This commitment is pivotal for fostering brand loyalty and repeat purchases.

Frequently Asked Questions

What was Chewy's revenue for Q3 2024?

Chewy reported a net sales figure of $2.88 billion for the third quarter of fiscal 2024.

How did Chewy's net income change in Q3 2024?

Chewy's net income for the third quarter was $3.9 million, an increase attributed to effective operational strategies.

What does the adjusted EBITDA indicate for Chewy?

The adjusted EBITDA for Chewy was $138.2 million, indicating robust operational performance and a $55.7 million increase year-over-year.

How has Chewy's customer base evolved?

The company observed a sequential increase in active customers, showcasing an effective customer engagement strategy.

Where can I find more information about Chewy's corporate activities?

For further details, you can visit Chewy's investor relations page or tune into the upcoming conference call scheduled for this morning.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 594

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 157

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 547

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 308

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 505

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 421

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 453

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 499

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading

Top 5 Most Recently Viewed Articles

Antengene's XPOVIO® Gains Approval in Thailand for Cancer Treatment

Updated Category News Views 114

Antengene's Recent Approval of XPOVIO® in Thailand Antengene Corporation Limited, a distinguished global biopharmaceutical company, has reached a notable achievement with the approval of XPOVIO® (selinexor) by the Thailand Food and Drug Administration. This approval marks XPOVIO® as the first and only XPO1 inhibitor authorized for sale in the Thai market. The drug,...

Continue Reading
Monumental Pediatric Surgery Advances at Nicklaus Children

Updated Category News Views 23

Redefining Pediatric Surgery with Mixed Reality Cue the drumroll, because Nicklaus Children's Hospital in Miami just pulled off a doozy in the medical field. The region's first pediatric total hip replacement using mixed reality-assisted guidance has taken place, and the ripples from this bad boy could be significant. The Hero of the Hour: Dr. Thomas J. Utset-Ward Dr....

Continue Reading
Contrasting Luxury Real Estate Trends in the U.S. Market

Updated Category News Views 151

The Evolving Landscape of U.S. Luxury Real Estate In the world of luxury real estate, change is the only constant. A recent report sheds light on how the U.S. luxury housing market is adapting to buyer preferences, with 2026 marking an interesting phase in pricing stabilization. Nationally, entry-level luxury prices stand steady at $1.19 million, but the interpretation of...

Continue Reading
Bureau Veritas Explores Potential Merger with SGS

Updated Category News Views 325

Exploring Business Synergies: Bureau Veritas and SGS Recent media discussions have shed light on the evolving landscape of Bureau Veritas as it engages in talks with SGS about the possibility of a business merger. This potential union reflects the growing trend within industries to enhance competencies and create greater value through collaboration. Bureau Veritas, a...

Continue Reading
Equifax Engages Investors in September Conferences Overview

Updated Category News Views 133

Equifax Invites Investors to Upcoming Conferences Equifax®, a leading data, analytics, and technology company recognized by its stock symbol EFX on the NYSE, is gearing up to engage with investors through several key conferences this September. This month presents an excellent opportunity for investors to gain insights into the company's strategy and future direction....

Continue Reading